
About Smilax Pharmaceuticals Private Limited
Data last updated:
Smilax Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1991PTC006078.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.4 Cr. It is led by directors Mukut Bihari Goyal and Mukta Goyal.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 66 Mathur Vaishya Nagar Tonk Road, Jaipur, Rajasthan, India – 302015.
As per the financials filed for FY 2024, the company reported a revenue of ₹32,000. For the same year it recorded a net profit of ₹4,022 (net margin 12.6%) and EBITDA of -₹12,832 (EBITDA margin -40.1%).
As per MCA filings, the company has satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smilaxgroup.net.
Company details
Contact details
Smilax Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its website is smilaxgroup.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address66 Mathur Vaishya Nagar Tonk Road, Jaipur, Rajasthan, India – 302015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Smilax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Smilax Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Smilax Pharmaceuticals Private Limited
FY 2025 filings availableSmilax Pharmaceuticals Private Limited reported revenue of ₹32,000 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹32,000 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12,832 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,022 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.1% | ||||
| Net Profit Margin | 12.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Smilax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Smilax Pharmaceuticals Private Limited
Smilax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukut Bihari Goyal | Director | 08 Jul 1991 | 35 Years 4 Months | Current |
| Mukta Goyal Also directs: Smilax Psyllium Impex LLP, Shiana Impex LLP, Duramed Healthcare (India) LLP and 3 more | Director | 08 Jul 1991 | 35 Years 4 Months | Current |
Auditor
Smilax Pharmaceuticals Private Limited is audited by S.R. SURANA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. SURANA & CO. | FY 2024 | 000990C |
Shareholding
The shareholding of Smilax Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Smilax Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2009 | 10158423 | Union Bank of India | ₹50 Lakh | Satisfied |
To see the full charge records of Smilax Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Smilax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smilax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Smilax Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Smilax Pharmaceuticals Private Limited has 2 board changes on record since 1991: 2 appointments. The latest: Mukta Goyal was appointed as Director on 08 Jul 1991.
Frequently asked questions
Smilax Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 1991 (35+ years old) and is registered under CIN U24232RJ1991PTC006078.
Smilax Pharmaceuticals has 2 current directors:
- Mukut Bihari Goyal - Director
- Mukta Goyal - Director
The latest financial statements of Smilax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Smilax Pharmaceuticals is U24232RJ1991PTC006078. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smilax Pharmaceuticals was incorporated on 08 July 1991, making it 35+ years old. It is registered with the Registrar of Companies, Jaipur.
Mukta Goyal was appointed as Director on 08 Jul 1991. Mukut Bihari Goyal was appointed as Director on 08 Jul 1991.
Smilax Pharmaceuticals can be reached through the website smilaxgroup.net. Its registered office is in Jaipur, Rajasthan, India.
The registered office of Smilax Pharmaceuticals is at 66 Mathur Vaishya Nagar Tonk Road, Jaipur, Rajasthan, India – 302015.
Smilax Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Smilax Pharmaceuticals has no open charges and satisfied charges of ₹50 Lakh as per latest MCA filings.

